| Date | Title | Description | Source |
| 05.03.2024 | Mereo BioPharma to Participate in Fireside Chat at the Leeri... | - | globenewsw... |
| 08.01.2024 | Mereo BioPharma Provides Update on Pipeline Progress and Cor... | Phase 3 portion of Orbit Study and Phase 3 Cosmic Study of setrusumab for treatment of Osteogenesis ... | einpresswi... |
| 05.06.2023 | Ultragenyx and Mereo BioPharma Announce Positive Data from t... | /EIN News/ -- Pediatric data show substantial induction of bone production in 1 week and a large inc... | einpresswi... |
| 31.05.2023 | Mereo BioPharma to Present at the Jefferies Healthcare Confe... | /EIN News/ -- LONDON, May 31, 2023 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Me... | einpresswi... |
| 05.05.2023 | Mereo BioPharma Announces Listing Transfer to Nasdaq Capital... | /EIN News/ -- LONDON, May 05, 2023 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Me... | einpresswi... |
| 28.10.2022 | Mereo BioPharma Reaches Cooperation Agreement with Rubric Ca... | Mereo to Appoint Four New Directors to its Board of Directors
Rubric has Withdrawn its General Meeti... | globenewsw... |
| 28.10.2022 | Mereo BioPharma Reaches Cooperation Agreement with Rubric Ca... | /EIN News/ -- Mereo to Appoint Four New Directors to its Board of Directors
Rubric has Withdrawn its... | einpresswi... |
| 24.10.2022 | Mereo BioPharma to Host Alvelestat R&D Update Call on Oc... | LONDON, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or “the... | globenewsw... |
| 21.10.2022 | Mereo BioPharma Files Shareholder Circular for Upcoming Gene... | Reiterates Quality and Composition of Mereo’s Significantly Refreshed Board, which has the Right Ski... | globenewsw... |
| 18.10.2022 | Mereo BioPharma Announces Updated Operating Plan to Maximize... | Targets 40% Reduction in Headcount and Significant Expense Reductions as Company Continues to Guide ... | globenewsw... |
| 17.10.2022 | Mereo BioPharma Receives FDA Fast Track Designation for Alve... | Designation Validates Alvelestat’s Potential to Address a Serious Unmet Need
Company Plans R&D U... | globenewsw... |
| 03.10.2022 | Mereo BioPharma Confirms Receipt of a Valid Notice Requiring... | Rubric has Rejected Mereo’s Reasonable Settlement Proposal and has Escalated its Costly, Distracting... | globenewsw... |
| 26.09.2022 | Mereo BioPharma Offered to Settle Proxy Contest with Rubric ... | Rubric Summarily Rejected the Proposal and Refused to Provide a Counteroffer
Rubric’s Second General... | globenewsw... |
| 12.09.2022 | Mereo BioPharma Reports Clinical Update and Interim Biomarke... | Data support further evaluation of PVR, CD226, and TIGIT as potential biomarkers of enrichment for e... | globenewsw... |
| 09.09.2022 | Ultragenyx and Mereo BioPharma to Present Setrusumab Data Up... | NOVATO, Calif. and MOUNTAIN VIEW, Calif. and LONDON, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Ultragenyx P... | globenewsw... |
| 31.08.2022 | Mereo BioPharma Sends Letter to Rubric Capital Management | Letter Reiterates Mereo’s Updated Strategic Plan to Maximize Value for All Shareholders and Corrects... | globenewsw... |
| 22.08.2022 | Mereo BioPharma Sends Letter to Rubric Capital Management | LONDON, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or “the... | globenewsw... |
| 05.07.2022 | Mereo BioPharma Regains Compliance with Nasdaq Minimum Bid P... | LONDON and MOUNTAIN VIEW, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDA... | globenewsw... |
| 02.06.2022 | Mereo BioPharma To Present Data Update for the Phase 1b/2 St... | --ACTIVATE includes 2 Complete Responses, 4 Partial Responses and 10 patients with Stable Disease as... | globenewsw... |
| 26.05.2022 | Mereo BioPharma Received Notification of Nasdaq Minimum Bid ... | LONDON and REDWOOD CITY, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ:... | globenewsw... |
| 26.05.2022 | Mereo BioPharma Announces the Presentation of Updated Data F... | Phase 1b/2 Study of Etigilimab and Nivolumab in Subjects with Select Locally Advanced or Metastatic ... | globenewsw... |
| 17.05.2022 | Mereo BioPharma Announces Appointment of Dr. Abdul Mullick t... | LONDON and REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ:... | globenewsw... |
| 09.05.2022 | Mereo BioPharma announces Positive Top-Line Efficacy and Saf... | Statistically significant inhibition of blood neutrophil elastase activity of up to 90% in patients ... | globenewsw... |
| 06.05.2022 | Mereo BioPharma to Host Conference Call Highlighting Top-lin... | LONDON and REDWOOD CITY, Calif., May 06, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ:... | globenewsw... |
| 06.04.2022 | Mereo BioPharma to Participate in Fireside Chat at the 21st ... | LONDON and REDWOOD CITY, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDA... | globenewsw... |
| 31.03.2022 | Mereo BioPharma Reports Full Year 2021 Financial Results and... | LONDON and REDWOOD CITY, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDA... | globenewsw... |
| 03.03.2022 | Mereo BioPharma to Hold Virtual R&D Day on Monday, March... | LONDON and REDWOOD CITY, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDA... | globenewsw... |
| 01.03.2022 | Mereo BioPharma Announces Appointment of Anne Hyland to Boar... | LONDON and REDWOOD CITY, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDA... | globenewsw... |
| 10.02.2022 | Mereo BioPharma to Participate in Fireside Chat at the 11th ... | LONDON and REDWOOD CITY, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ... | globenewsw... |
| 22.12.2021 | UAB and Mereo Announce Positive Top-line Results from “COSTA... | Alvelestat reported safe and well-tolerated in patients with COVID-19
Alvelestat, on top of standard... | globenewsw... |
| 22.12.2021 | UAB and Mereo Announce Positive Top-line Results from “COSTA... | Alvelestat reported safe and well-tolerated in patients with COVID-19
Alvelestat, on top of standard... | marketscre... |
| 13.12.2021 | Biomarker Data from Phase 1b/2 Investigator-sponsored Trial ... | LONDON and REDWOOD CITY, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ... | globenewsw... |
| 30.11.2021 | Mereo BioPharma Reports Interim Data from ACTIVATE Phase 1b/... | One complete response, one partial response and four cases of stable disease observed among 15 patie... | globenewsw... |
| 09.11.2021 | Mereo BioPharma to Present at Two Upcoming Investor Conferen... | LONDON and REDWOOD CITY, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ... | globenewsw... |
| 04.11.2021 | Data from Investigator-sponsored Trial of Mereo BioPharma’s ... | LONDON and REDWOOD CITY, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ... | globenewsw... |
| 26.10.2021 | Mereo Receives U.S. Orphan Drug Designation for alvelestat i... | Mereo BioPharma Receives U.S. Orphan Drug Designation for alvelestat in
the Treatment of alpha-1 ant... | marketscre... |
| 26.10.2021 | Mereo BioPharma Receives U.S. Orphan Drug Designation for al... | LONDON and REDWOOD CITY, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ... | globenewsw... |
| 14.10.2021 | Mereo BioPharma : OIFE and OIF announce completion of the IM... | Mereo BioPharma Group plc
Mereo BioPharma, the Osteogenesis Imperfecta Federation Europe (OIFE) and ... | marketscre... |
| 13.10.2021 | Mereo BioPharma, the Osteogenesis Imperfecta Federation Euro... | Living With Osteogenesis IMPerfecta: UnderstAnding Experiences Based On Community InsighT and Eviden... | globenewsw... |
| 02.06.2021 | MEREO BIOPHARMA GROUP PLC
Mereo BioPharma : Announces Posit... | Mereo BioPharma Group plc
Mereo BioPharma to Participate in a Fireside Chat at the Jefferies 2021 Vi... | marketscre... |
| 01.04.2021 | MEREO BIOPHARMA GROUP PLC
Mereo BioPharma Reports Full Year... | -- Ultragenyx Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta --
-- Fu... | marketscre... |
| 18.02.2021 | Mereo BioPharma to Participate in a Fireside Chat at the 10t... | LONDON and REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ... | globenewsw... |
| 12.02.2021 | Mereo BioPharma Group plc Announces Closing of Public Offeri... | LONDON and REDWOOD CITY, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ... | globenewsw... |
| 11.11.2020 | MEREO BIOPHARMA GROUP PLC
Mereo BioPharma : Announces Inten... | THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. ... | marketscre... |
| 11.11.2020 | Mereo BioPharma : Announces Intention to Continue Listing It... | THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. ... | marketscre... |
| 29.09.2020 | MEREO BIOPHARMA GROUP PLC
Mereo BioPharma Announces Interim... | On track to initiate Phase 1b/2 etigilimab (Anti-TIGIT) combination study in Q4 2020
Enrolment resum... | marketscre... |
| 29.09.2020 | MEREO BIOPHARMA GROUP PLC
Mereo BioPharma : Announces Inter... | On track to initiate Phase 1b/2 etigilimab (Anti-TIGIT) combination study in Q4 2020
Enrolment resum... | marketscre... |
| 29.09.2020 | MEREO BIOPHARMA GROUP PLC
Mereo BioPharma : Interim Financi... | Mereo BioPharma Group plc
Mereo BioPharma Announces Interim Financial Results for the Six Months End... | marketscre... |
| 16.06.2020 | MEREO BIOPHARMA GROUP PLC
Mereo BioPharma Announces Financi... | LONDON and REDWOOD CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ... | marketscre... |
| 10.04.2018 | Term Sheet — Tuesday, April 10 | BIKE SHARING WARS
The bike-sharing war is roaring in the United States following its explosive popul... | fortune.co... |
| 26.03.2018 | With Big Pharma castoffs in hand, Mereo files for $81M IPO;... | → Mereo BioPharma, a London biotech developing a pipeline of assets it snagged from Big Phar... | endpts.com... |
| 19.03.2018 | Homology, Unum set IPO terms; Knight pays Ardelyx $19M f... | → Two biotechs in Boston have set the terms for their IPOs: Homology Medicines plans to raise $... | endpts.com... |
| 30.10.2017 | Mereo bags rights to the latest AstraZeneca castoff, shift... | Denise Scots-Knight
→ London-based Mereo BioPharma has picked off an option on the rights to a P... | endpts.com... |
| 29.07.2015 | Mereo BioPharma Raises $119M in Funding | Mereo BioPharma Group Ltd, a London, UK-based speciality biopharmaceutical company, raised $119m (c.... | finsmes.co... |
